| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 7L3WOA232W |
Structure
| InChI Key | HTLWMOKBJQKDIJ-WJOKGBTCSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C35H47N5O6 |
| Molecular Weight | 633.79 |
| AlogP | 3.93 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 114.89 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 46.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Calcitonin gene-related peptide type 1 receptor antagonist | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family B G protein-coupled receptor
Peptide receptor (family B GPCR)
Calcitonin-like receptor
Calcitonin gene-related peptide receptor
|
- | 0 | - | 0 | - | |
|
Other membrane protein
|
- | 0 | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Migraine Disorders | 2 | D008881 | ClinicalTrials |
Related Entries
Scaffolds
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3334624 |
| DrugBank | DB16037 |
| FDA SRS | 7L3WOA232W |
| SureChEMBL | SCHEMBL2088321 |
| ZINC | ZINC000117997024 |
CONTENTS